Nicoya has developed Alto, the world’s first digital high-throughput benchtop SPR instrument. It is capable of accelerating drug discovery using a fraction of sample volume traditionally required for biomolecular interaction analyses. Alto helps biotechnology and pharmaceutical companies go to market faster with increased efficiency and success early in their product pipelines.

“DKSH has unique regional coverage, in-depth knowledge and a broad network of laboratories doing research on biomolecules and nanoparticles. We are convinced that DKSH is the right partner to help us excel in the demanding scientific application for SPR, expand our coverage and meet our aggressive growth goals,” said David Panzarella, Chief Commercial Officer, Nicoya.

Marco Farina, Senior Director, Business Development, Scientific Instrumentation, DKSH Business Unit Technology, commented: “The partnership with Nicoya helps strengthen our leadership in the characterization of biomolecular interactions and expand our life sciences footprint. We are confident to grow the market with Nicoya, leveraging our expertise through our Center of Excellence, good sales coverage, strong application support and world-class after-sales services.”